[Form 4] SI-BONE, Inc. Insider Trading Activity
Rhea-AI Filing Summary
SI-BONE insider sale tied to RSU tax withholding: Laura A. Francis, who serves as both Chief Executive Officer and a director, reported multiple dispositions of her common stock to satisfy tax withholding on vested restricted stock units. The transactions on 08/18/2025 consisted of five grouped sales totaling 11,343 shares disposed at weighted-average prices in the roughly $15.52–$15.83 range, producing the reported per-trade weighted averages shown. After these transactions the filing shows Ms. Francis directly beneficially owns 419,704 shares and indirectly owns 362,141 shares through The David & Laura Joint Rev Tr., with 396,297 shares included as shares issuable upon settlement of RSUs.
Positive
- Insider ownership remains substantial: combined direct and indirect holdings indicate continued CEO alignment with shareholders
- Sale explicitly disclosed as sell-to-cover for RSU tax withholding, indicating the transactions were administrative rather than discretionary
Negative
- None.
Insights
TL;DR: CEO sold shares to cover RSU tax withholding; transaction is standard compensation-related activity and not a discretionary market signal.
The Form 4 discloses a series of sell-to-cover transactions tied to vesting restricted stock units, which is a common practice for executives to satisfy tax obligations. The disclosure identifies both direct and indirect holdings, including substantial trust-held shares, which maintains continuity of insider ownership. No new option grants, open-market discretionary purchases, or material changes in ownership percentage are reported that would suggest a governance or control shift.
TL;DR: Transactions are routine sell-to-cover of RSUs; they modestly reduce direct holdings but leave significant insider ownership intact.
The reported sales total 11,343 shares executed across multiple trades with reported weighted-average prices and are explicitly tied to tax withholding. Post-transaction direct and indirect holdings remain large (over 780,000 combined when adding direct and trust holdings), suggesting limited immediate impact on float or on investor perception of insider alignment. No derivative exercises, new grants, or other compensatory changes are disclosed on this Form 4.